| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/00002371-200001000-00004 |
| P698 | PubMed publication ID | 10687134 |
| P50 | author | Steven Rosenberg | Q2347448 |
| P2093 | author name string | Wang X | |
| Wang RF | |||
| Kawakami Y | |||
| Robbins PF | |||
| Dang N | |||
| Yannelli JR | |||
| Wunderlich JR | |||
| Tupesis J | |||
| P2860 | cites work | The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas | Q36362111 |
| P433 | issue | 1 | |
| P304 | page(s) | 17-27 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Journal of Immunotherapy | Q15763946 |
| P1476 | title | Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma | |
| P478 | volume | 23 |
| Q41520738 | Antitumor immunity and cancer stem cells |
| Q77839001 | CD3-zetachain expression of intratumoral lymphocytes is closely related to survival in gastric carcinoma patients |
| Q91790659 | Computing Skin Cutaneous Melanoma Outcome From the HLA-Alleles and Clinical Characteristics |
| Q35190925 | Creating therapeutic cancer vaccines: notes from the battlefield |
| Q87654030 | Deciphering the unusual HLA-A2/Melan-A/MART-1-specific TCR repertoire in humans |
| Q33750205 | Expansion and characterization of human melanoma tumor-infiltrating lymphocytes (TILs) |
| Q36835348 | Frequency of MART-1/MelanA and gp100/PMel17-specific T cells in tumor metastases and cultured tumor-infiltrating lymphocytes |
| Q38798375 | Functional cloning of a gp100-reactive T-cell receptor from vitiligo patient skin |
| Q33185580 | Genetic engineering of T cell specificity for immunotherapy of cancer |
| Q36471584 | High efficiency TCR gene transfer into primary human lymphocytes affords avid recognition of melanoma tumor antigen glycoprotein 100 and does not alter the recognition of autologous melanoma antigens |
| Q90776194 | Identification of Small Molecule Enhancers of Immunotherapy for Melanoma |
| Q28215622 | Identification of a novel gp100/pMel17 peptide presented by HLA-A*6801 and recognized on human melanoma by cytolytic T cell clones |
| Q36863359 | Identification of an Immunogenic Subset of Metastatic Uveal Melanoma |
| Q34167925 | Immunity against cancer: lessons learned from melanoma. |
| Q33755576 | Impact of Human Leukocyte Antigen Loci and Haplotypes on Intestinal Acute Graft-versus-host Disease after Human Leukocyte Antigen-matched Sibling Peripheral Blood Stem Cell Transplantation |
| Q28607232 | Impaired gp100-Specific CD8(+) T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma Model |
| Q36973086 | Imprinting of lymphocytes with melanoma antigens acquired by trogocytosis facilitates identification of tumor-reactive T cells |
| Q30767834 | Mining the melanosome for tumor vaccine targets: P.polypeptide is a novel tumor-associated antigen |
| Q84582609 | Multi-compartmental vaccine delivery system for enhanced immune response to gp100 peptide antigen in melanoma immunotherapy |
| Q52719267 | Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress. |
| Q36696205 | Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma |
| Q36734688 | Multiple vaccinations: friend or foe. |
| Q38761397 | Neoantigen landscape dynamics during human melanoma-T cell interactions |
| Q36832141 | Novel antibodies as anticancer agents |
| Q33210267 | Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy |
| Q42907201 | Preclinical Qualification of a New Multi-antigen Candidate Vaccine for Metastatic Melanoma |
| Q37987723 | T-cell-receptor-like antibodies - generation, function and applications |
| Q39160959 | TAM receptor tyrosine kinases as emerging targets of innate immune checkpoint blockade for cancer therapy |
| Q38856722 | Targeted agents and immunotherapies: optimizing outcomes in melanoma |
| Q34293564 | Transcutaneous immunization with hydrophilic recombinant gp100 protein induces antigen-specific cellular immune response |
| Q34669675 | Transfer of a TCR gene derived from a patient with a marked antitumor response conveys highly active T-cell effector functions |
| Q36371632 | Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. |
| Q37801388 | Vitiligo, reactive oxygen species and T-cells |
Search more.